CTMX
USDCytomX Therapeutics Inc. Common Stock
$4.090+0.290 (7.632%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$3.800
High
$4.180
Low
$3.710
Volume
4.81M
Company Fundamentals
Market Cap
674.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
3.77M
Exchange
NMS
Currency
USD
52-Week Range
Low $0.4Current $4.090High $4.18
Related News
GlobeNewswire
CytomX Therapeutics to Present CX-801 Phase 1 Monotherapy Biomarker Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
- CX-801 (PROBODY® interferon alpha-2b) Phase 1 data demonstrate activation of tumor-selective interferon signaling in patients with advanced melanoma - - Data supportive of CX-801's mechanism of action and the
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.